The SCA has approved Orifarm’s acquisition of some assets from Takeda, despite some very high resulting combined market shares in OTC and prescription pharmaceutical products sold in Sweden, as price caps and new entries through imports are assumed to prevent increasing prices. In other news, the Nordic competition authorities have published a joint memorandum on digital platforms, Sweden has asked for a European preliminary ruling on a public procurement case, and the EU Commission has approved the Worldline-Ingencio merger while opening an in-depth investigation of the Danfoss – Eaton Hydraulics merger.
Continue reading